{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:19:04Z","timestamp":1794853144283,"version":"4.9.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.parkreldis.2016.10.024","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T21:01:58Z","timestamp":1478034118000},"page":"8-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"special_numbering":"C","title":["Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-9952","authenticated-orcid":false,"given":"Claire","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Winge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Burn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.parkreldis.2016.10.024_bib1","first-page":"223","article-title":"An essay on the shaking palsy","volume":"2002","author":"Parkinson","year":"1817","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.parkreldis.2007.09.002","article-title":"Nonmotor symptoms of parkinson's disease: prevalence and awareness of patients and families","volume":"14","author":"Cheon","year":"2008","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jnnp.68.4.429","article-title":"Assessment of voiding dysfunction in parkinson's disease by the international prostate symptom score","volume":"68","author":"Araki","year":"2000","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1566-0702(01)00295-8","article-title":"Questionnaire-based assessment of pelvic organ dysfunction in parkinson's disease","volume":"92","author":"Sakakibara","year":"2001","journal-title":"Aut. Neurosci. Basic Clin."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib5","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.21667","article-title":"Quality of life in parkinson's disease: the relative importance of the symptoms","volume":"23","author":"Rahman","year":"2008","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib6","first-page":"1310","article-title":"Falls in outpatients with parkinson's disease: frequency, impact and identifying factors","volume":"252","author":"Balash","year":"2005","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0004-282X2003000300007","article-title":"Urinary symptoms in parkinson's disease: prevalence and associated factors","volume":"61","author":"Campos-Sousa","year":"2003","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib8","first-page":"181","article-title":"Voiding dysfunction in parkinson's disease","volume":"46","author":"Hattori","year":"1992","journal-title":"Jpn. J. Psychiatry Neurol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.parkreldis.2003.07.001","article-title":"The risk of bladder and autonomic dysfunction in a community cohort of parkinson's disease patients and normal controls","volume":"10","author":"Hobson","year":"2003","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib10","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.4103\/0366-6999.168049","article-title":"Investigation of urination disorder in parkinson's disease","volume":"128","author":"Zhang","year":"2015","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s11255-015-0951-y","article-title":"Underactive and overactive bladders are related to motor function and quality of life in parkinson's disease","volume":"47","author":"Liu","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/nau.20193","article-title":"Prevalence of bladder dysfunction in parkinsons disease","volume":"25","author":"Winge","year":"2006","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1442-2042.2012.03220.x","article-title":"Effective management of lower urinary tract dysfunction in idiopathic parkinson's disease","volume":"20","author":"Kapoor","year":"2013","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib14","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/nau.20983","article-title":"Idiopathic parkinson's disease patients at the urologic clinic","volume":"30","author":"Ragab","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib15","first-page":"1549","article-title":"The american urological association symptom index for benign prostatic hyperplasia. The measurement committee of the american urological association","volume":"148","author":"Barry","year":"1992","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1464-410X.1995.tb07744.x","article-title":"Validation of the self-administered danish prostatic symptom score (dan-pss-1) system for use in benign prostatic hyperplasia","volume":"76","author":"Hansen","year":"1995","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib17","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for parkinson's disease: results from an international pilot study","volume":"22","author":"Chaudhuri","year":"2007","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.10.024_bib18","first-page":"2","article-title":"Quantitation of non-motor symptoms in parkinson's disease","volume":"15","author":"Chaudhuri","year":"2008","journal-title":"Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib19","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The priamo study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in parkinson's disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib20","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/jnnp.2011.241075","article-title":"Urinary dysfunction in early and untreated parkinson's disease","volume":"82","author":"Uchiyama","year":"2011","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the international continence society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/jnnp.67.5.658","article-title":"Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function","volume":"67","author":"Sakakibara","year":"1999","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib23","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.4081\/ni.2012.e13","article-title":"Vascular incontinence: incontinence in the elderly due to ischemic white matter changes","volume":"4","author":"Sakakibara","year":"2012","journal-title":"Neurol. Int."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e31827deb74","article-title":"The spectrum of nonmotor symptoms in early parkinson disease","volume":"80","author":"Khoo","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.67.5.620","article-title":"Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study","volume":"67","author":"Wenning","year":"1999","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1179\/1743132813Y.0000000264","article-title":"Prevalence of nocturia in parkinson's disease patients from various ethnicities","volume":"36","author":"Rana","year":"2014","journal-title":"Neurol. Res."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/iju.12186","article-title":"Finger taps and constipation are closely related to symptoms of overactive bladder in male patients with parkinson's disease","volume":"21","author":"Tsujimura","year":"2014","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0090-4295(00)00641-5","article-title":"Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate parkinson's disease","volume":"56","author":"Lemack","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib29","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/nau.22237","article-title":"Bladder dysfunction in advanced parkinson's disease","volume":"31","author":"Winge","year":"2012","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib30","first-page":"1405","article-title":"Autonomic dysfunction in 3414 parkinson's disease patients enrolled in the german network on parkinson's disease (knp e.V.): the effect of ageing","volume":"14","author":"Wullner","year":"2007","journal-title":"Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JNN.0b013e3182a3cf67","article-title":"Lower urinary tract symptoms in men with parkinson disease","volume":"45","author":"Robinson","year":"2013","journal-title":"J.\u00a0Neurosci. Nurs. J. Am. Assoc. Neurosci. Nurses"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/mds.870120406","article-title":"Urinary disturbances in striatonigral degeneration and parkinson's disease: clinical and urodynamic aspects","volume":"12","author":"Bonnet","year":"1997","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib33","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.parkreldis.2014.04.023","article-title":"Gender differences in non-motor symptoms in early parkinson's disease: a 2-years follow-up study on previously untreated patients","volume":"20","author":"Picillo","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2015.11.047","article-title":"Progression of non-motor symptoms in parkinson's disease among different age populations: a two-year follow-up study","volume":"360","author":"Ou","year":"2016","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1590\/0004-282X20130101","article-title":"Urinary dysfunction with detrusor hyperactivity in women with parkinson's disease cannot be blamed as a factor of worsening motor performance","volume":"71","author":"Campos-Sousa","year":"2013","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/jnnp.71.5.600","article-title":"Videourodynamic and sphincter motor unit potential analyses in parkinson's disease and multiple system atrophy","volume":"71","author":"Sakakibara","year":"2001","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib37","first-page":"1640","article-title":"Voiding dysfunction and parkinson's disease: urodynamic abnormalities and urinary symptoms","volume":"164","author":"Araki","year":"2000","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jnnp.62.5.507","article-title":"Urodynamic and neurophysiological evaluation in parkinson's disease and multiple system atrophy","volume":"62","author":"Stocchi","year":"1997","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0090-4295(03)00507-7","article-title":"Distinguishing neurogenic from non-neurogenic detrusor overactivity: a urodynamic assessment of lower urinary tract symptoms in patients with and without parkinson's disease","volume":"62","author":"Defreitas","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib40","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/mds.25225","article-title":"Weak detrusor contractility correlates with motor disorders in parkinson's disease","volume":"27","author":"Terayama","year":"2012","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.nbd.2011.10.002","article-title":"Pathophysiology of bladder dysfunction in parkinson's disease","volume":"46","author":"Sakakibara","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn2401","article-title":"The neural control of micturition","volume":"9","author":"Fowler","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/nau.20371","article-title":"Update on the neurology of parkinson's disease","volume":"26","author":"Fowler","year":"2007","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/apha.12019","article-title":"The micturition switch and its forebrain influences","volume":"207","author":"Griffiths","year":"2013","journal-title":"Acta Physiol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.22519","article-title":"Genitourinary dysfunction in parkinson's disease","volume":"25","author":"Sakakibara","year":"2010","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3565(24)37579-2","article-title":"Therapeutic effects of dopamine d1\/d2receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys","volume":"286","author":"Yoshimura","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0304-3940(88)90143-7","article-title":"Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"87","author":"Albanese","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib49","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/sj.bjp.0705388","article-title":"Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-ohda) lesion of the nigrostriatal pathway","volume":"139","author":"Yoshimura","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib50","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1254\/jjp.54.482","article-title":"Dopamine receptor subtypes that induce hyperactive urinary bladder response in anesthetized rats","volume":"54","author":"Kontani","year":"1990","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1520-6777(2001)20:1<105::AID-NAU12>3.0.CO;2-9","article-title":"Role of dopamine d1 and d2 receptors in the micturition reflex in conscious rats","volume":"20","author":"Seki","year":"2001","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib52","first-page":"R935","article-title":"Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion","volume":"276","author":"Yokoyama","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-510X(01)00521-4","article-title":"Spect imaging of the dopamine transporter with [(123)i]-beta-cit reveals marked decline of nigrostriatal dopaminergic function in parkinson's disease with urinary dysfunction","volume":"187","author":"Sakakibara","year":"2001","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib54","first-page":"842","article-title":"Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in parkinson's disease","volume":"12","author":"Winge","year":"2005","journal-title":"Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/mds.21253","article-title":"Lower urinary tract symptoms and bladder control in advanced parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus","volume":"22","author":"Winge","year":"2007","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.parkreldis.2011.05.009","article-title":"The impact of bilateral subthalamic stimulation on non-motor symptoms of parkinson's disease","volume":"17","author":"Nazzaro","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib57","first-page":"15","article-title":"Efficacy of deep brain stimulation of the subthalamic nucleus on autonomic dysfunction in patients with parkinson's disease","volume":"53","author":"Pietraszko","year":"2013","journal-title":"Folia Med. Cracov"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib58","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.parkreldis.2014.05.016","article-title":"Bladder function in patients with dystonia undergoing deep brain stimulation","volume":"20","author":"Mordasini","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib59","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1093\/brain\/awl302","article-title":"Subthalamic stimulation modulates cortical control of urinary bladder in parkinson's disease","volume":"129","author":"Herzog","year":"2006","journal-title":"Brain A J. Neurol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ana.10806","article-title":"Effect of subthalamic deep brain stimulation on the function of the urinary bladder","volume":"55","author":"Seif","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib61","first-page":"1388","article-title":"Effects of subthalamic nucleus stimulation on urodynamic findings in patients with parkinson's disease","volume":"169","author":"Finazzi-Agro","year":"2003","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib62","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/iju.12721","article-title":"Brain-bladder control network: the unsolved 21st century urological mystery","volume":"22","author":"Kitta","year":"2015","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/nau.21222","article-title":"Correlation of right frontal hypoperfusion and urinary dysfunction in inph: a spect study","volume":"31","author":"Sakakibara","year":"2012","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib64","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/MNM.0b013e328313bc13","article-title":"Cerebral control of bladder storage in patients with detrusor overactivity","volume":"29","author":"Yin","year":"2008","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib65","first-page":"994","article-title":"Brain activation during detrusor overactivity in patients with parkinson's disease: a positron emission tomography study","volume":"175","author":"Kitta","year":"2006","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib66","first-page":"1613","article-title":"Role of the anterior cingulate cortex in the control of micturition reflex in a rat model of parkinson's disease","volume":"195","author":"Kitta","year":"2016","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib67","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mds.26605","article-title":"Neuropathological basis of nonmotor manifestations of parkinson's disease","volume":"31","author":"Adler","year":"2016","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib68","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.25776","article-title":"Multiple organ involvement by alpha-synuclein pathology in lewy body disorders","volume":"29","author":"Gelpi","year":"2014","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib69","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ana.24430","article-title":"Alpha-synuclein pathology accumulates in sacral spinal visceral sensory pathways","volume":"78","author":"VanderHorst","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib71","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","article-title":"An international urogynecological association (iuga)\/international continence society (ics) joint report on the terminology for female pelvic floor dysfunction","volume":"21","author":"Haylen","year":"2010","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib72","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.eururo.2015.07.071","article-title":"Summary of european association of urology (eau) guidelines on neuro-urology","volume":"69","author":"Groen","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib73","doi-asserted-by":"crossref","first-page":"e5074","DOI":"10.1136\/bmj.e5074","article-title":"Management of lower urinary tract dysfunction in neurological disease: summary of nice guidance","volume":"345","author":"Swain","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib74","series-title":"Lower Urinary Tract Symptoms in Men: Management","year":"2015"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib75","series-title":"Urinary Incontience in Neuological Disease: Managment of Lower Urinary Tract Dysfunction in Neurological Disease. UK","year":"2012"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib76","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/WNL.0b013e318219fab3","article-title":"Behavioral therapy to treat urinary incontinence in parkinson disease","volume":"76","author":"Vaughan","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib77","series-title":"Guidelines on the Clinical Investigation of Medicinal Products for the Treatment of Urinary Incontinence","year":"2013"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/nau.1930120302","article-title":"Effects of apomorphine and l-dopa on the parkinsonian bladder","volume":"12","author":"Aranda","year":"1993","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib79","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/mds.10403","article-title":"Short-term effect of a single levodopa dose on micturition disturbance in parkinson's disease patients with the wearing-off phenomenon","volume":"18","author":"Uchiyama","year":"2003","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib80","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/mds.22840","article-title":"Comparing bromocriptine effects with levodopa effects on bladder function in parkinson's disease","volume":"24","author":"Uchiyama","year":"2009","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib81","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1212\/01.wnl.0000260605.12506.86","article-title":"Acute vs chronic effects of l-dopa on bladder function in patients with mild parkinson disease","volume":"68","author":"Brusa","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib82","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.parkreldis.2014.04.020","article-title":"Rasagiline effect on bladder disturbances in early mild parkinson's disease patients","volume":"20","author":"Brusa","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib83","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(88)90932-4","article-title":"Role of subcutaneous apomorphine in parkinsonian voiding dysfunction","volume":"2","author":"Christmas","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib84","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2165\/00003495-200666100-00005","article-title":"Pharmacotherapy for overactive bladder: an evidence-based approach to selecting an antimuscarinic agent","volume":"66","author":"Appell","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib85","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.parkreldis.2007.10.016","article-title":"Urinary dysfunction in parkinson's disease: a review","volume":"15","author":"Blackett","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib86","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in parkinson's disease","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib87","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib88","doi-asserted-by":"crossref","first-page":"e0150621","DOI":"10.1371\/journal.pone.0150621","article-title":"Associations between anticholinergic burden and adverse health outcomes in parkinson disease","volume":"11","author":"Crispo","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib89","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.2009.186239","article-title":"Use of drugs with anticholinergic effect and impact on cognition in parkinson's disease: a cohort study","volume":"81","author":"Ehrt","year":"2010","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib90","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.eururo.2012.10.016","article-title":"Efficacy and tolerability of mirabegron, a beta(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised european-australian phase 3 trial","volume":"63","author":"Khullar","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib91","first-page":"829","article-title":"A\u00a0systematic review of the efficacy and safety of desmopressin for nocturia in adults","volume":"192","author":"Ebell","year":"2014","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib92","first-page":"S7","article-title":"Desmopressin in the treatment of nocturia in patients affected by neurogenic bladder","volume":"33","author":"Giannantoni","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib93","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.870100318","article-title":"Beneficial effect of intranasal desmopressin for nocturnal polyuria in parkinson's disease","volume":"10","author":"Suchowersky","year":"1995","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib94","series-title":"Nasal Formulations of Desmopressin Are No Longer Indicated for Primary Nocturnal Enuresis","first-page":"1","year":"2007"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib95","series-title":"Information for Healthcare Professionals: Desmopressin Acetate (Marketed as Ddavp Nasal Spray, Ddavp Rhinal Tube, Ddavp, Ddvp, Minirin, and Stimate Nasal Spray)","author":"US Food and Drug Administration","year":"2007"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib96","series-title":"Nocturia and Nocturnal Polyuria in Men with Lower Urinary Tract Symptoms: Oral Desmopressin","author":"National Institute for Health and Care Excellence","year":"2013"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib97","doi-asserted-by":"crossref","first-page":"817","DOI":"10.6061\/clinics\/2014(12)05","article-title":"Neurological status predicts response to alpha-blockers in men with voiding dysfunction and parkinson's disease","volume":"69","author":"Gomes","year":"2014","journal-title":"Clin. Sao Paulo"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib98","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2013.09.017","article-title":"Onabotulinumtoxina office treatment for neurogenic bladder incontinence in parkinson's disease","volume":"83","author":"Anderson","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.parkreldis.2016.10.024_bib99","first-page":"960","article-title":"Botulinum toxin type a in patients with parkinson's disease and refractory overactive bladder","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.parkreldis.2010.06.006","article-title":"Use of botulinim toxin-a for the treatment of overactive bladder symptoms in patients with parkinsons's disease","volume":"16","author":"Kulaksizoglu","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib101","first-page":"117","article-title":"Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control","volume":"140","author":"Staskin","year":"1988","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.parkreldis.2016.10.024_bib102","first-page":"2209","article-title":"Benign prostatic obstruction and parkinson's disease\u2013should transurethral resection of the prostate be avoided?","volume":"181","author":"Roth","year":"2009","journal-title":"J.\u00a0Urol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016304291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016304291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:12:36Z","timestamp":1749669156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802016304291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":102,"alternative-id":["S1353802016304291"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.10.024","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}